Respiratory Tract Diseases Clinical Trials

7 recruiting

Respiratory Tract Diseases Trials at a Glance

7 actively recruiting trials for respiratory tract diseases are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Altdorf, Baden, and Basel. Lead sponsors running respiratory tract diseases studies include Drahomir Aujesky, Intuitive Surgical, and Aevice Health Pte. Ltd..

Browse respiratory tract diseases trials by phase

Treatments under study

About Respiratory Tract Diseases Clinical Trials

Looking for clinical trials for Respiratory Tract Diseases? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Respiratory Tract Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Respiratory Tract Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Collection of Lung Fluid and Tissue Samples for Research

Respiratory Tract DiseasesBronchoscopyLeukocyte Disorders
National Heart, Lung, and Blood Institute (NHLBI)550 enrolled1 locationNCT00471250
Recruiting

Real World Registry for Use of the Ion Endoluminal System

Lung CancerLung NeoplasmsNeoplasms+6 more
Intuitive Surgical3,000 enrolled16 locationsNCT06004440
Recruiting

AeviceMD for Detection of Wheeze in Pediatric and Adult Populations

AsthmaRespiratory Tract DiseasesChronic Respiratory Disease+3 more
Aevice Health Pte. Ltd.160 enrolled1 locationNCT06691971
Recruiting
Not Applicable

Early Intervention Strategies for Lung Cancer

Lung NeoplasmsNeoplasmsNeoplasms by Site+4 more
The First Affiliated Hospital of Guangzhou Medical University16,000 enrolled1 locationNCT06988943
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled39 locationsNCT04263038
Recruiting

M. Avium WGS During Mav-PD Treatment

Respiratory Tract DiseasesMycobacterium AviumMycobacterium Infections, Nontuberculous+2 more
University Health Network, Toronto40 enrolled1 locationNCT06266442
Recruiting
Phase 2

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Lung NeoplasmsNeoplasmsNeoplasms by Site+7 more
Nanfang Hospital, Southern Medical University62 enrolled1 locationNCT06177925